Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.60
+1.11 (20.22%)
At close: Aug 7, 2025, 4:00 PM
6.48
-0.12 (-1.82%)
After-hours: Aug 7, 2025, 7:58 PM EDT
Nevro Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.06 billion as of August 7, 2025. Its market cap has increased by 191.01% in one year.
Market Cap
1.06B
Enterprise Value
1.25B
1-Year Change
191.01%
Ranking
Category
Stock Price
$6.60
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.06B, an increase of 257.37%. That is a compound annual growth rate of 39.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 879.25M | 73.98% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |